Skor Sentimen Insider
Skor Sentimen Insider menemukan bahwa perusahaan-perusahaan tersebut dibeli oleh insider perusahaan.
Hal ini merupakan hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan-perusahaan dengan tingkat akumulasi insider tertinggi. Model penilaian menggunakan kombinasi jumlah bersih pembelian insider dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase float, dan total saham yang dimiliki oleh insider. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi terhadap rekan-rekannya, dan 50 adalah rata-ratanya.
Frekuensi Pembaruan: Harian
Lihat Pilihan Insider Teratas yang menyediakan daftar perusahaan dengan akumulasi insider tertinggi.
Skor Sentimen Pejabat
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Perusahaan.
Menurut definisi, Pejabat Korporat adalah Insider Korporat, tetapi tidak seperti beberapa Insider lainnya (10% Pemegang Saham dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat berdagang . (10% Pemegang Saham dan Anggota Dewan sering kali merupakan pengelola dana yang mengelola uang orang lain.) Oleh karena itu, insider trading yang dilakukan oleh Pejabat jauh lebih signifikan dan harus diperlakukan dengan tepat.
Seperti Skor Sentimen Insider, Skor Sentimen Pejabat adalah hasil model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Harian
Lihat Pilihan Insider Teratas yang menyediakan daftar perusahaan dengan sentimen insider tertinggi.
Metrik Utama Insider
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik insider. Peringkat persentil menunjukkan perbandingan perusahaan ini dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Misalnya, secara umum diterima bahwa pembelian insider adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian insider akan memiliki peringkat lebih tinggi dibandingkan perusahaan dengan lebih sedikit pembelian insider (atau bahkan penjualan insider).
Jumlah Bersih Pembelian Insider (Peringkat)
N/A
Jumlah Bersih Pembelian Insider adalah jumlah total pembelian insider dikurangi jumlah total pembelian insider dalam 90 hari terakhir. Peringkat persentil ditampilkan di sini (berkisar dari 0 hingga 100%).
Persentase Float yang Dibeli oleh Insider (Peringkat)
N/A
Persen Float yang Dibeli oleh Insider adalah jumlah total saham yang dibeli oleh insider dikurangi jumlah total saham yang dijual oleh insider dalam 90 hari terakhir, dibagi dengan total float dan dikalikan 100.
Grafik Perdagangan Insider
Cellectar Biosciences, Inc. Warrants expiring 8/20/2019 perdagangan insider ditunjukkan pada diagram berikut. Insider adalah pejabat, direktur, atau investor penting dalam suatu perusahaan. Secara umum, merupakan tindakan ilegal bagi insider untuk melakukan perdagangan di perusahaannya berdasarkan informasi penting yang bersifat non-publik. Hal ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan ke SEC melalui Formulir 4.
Daftar Insider dan Metrik Profitabilitas
Tabel ini menunjukkan daftar insider yang dikenal, dan dihasilkan secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan direktur, pejabat, atau 10% pemilik, kami juga menyediakan pengungkapan kepemilikan terkini. Selain itu, jika memungkinkan, kami memberikan riwayat kinerja perdagangan kepada insider. Kinerja perdagangan historis merupakan rata-rata tertimbang dari kinerja transaksi pembelian aktual di pasar terbuka yang dilakukan oleh insider. Untuk informasi selengkapnya tentang cara menghitungnya, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Insider | Laba Rata-Rata (%) | Saham Dimiliki |
Membelah Disesuaikan |
|---|
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Insider - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Rekam Jejak Penjualan Insider - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan ditandai X di kolom bertanda 10b-5.
| Mengajukan Tanggal |
Transaksi Tanggal |
Formulir | Insider | Kode | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Satuan Berubah |
Nilai Berubah (1K) |
Tersisa Opsi |
Tersisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | 2026-05-07 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 2,8800 | 8.680 | 25 | 20.451 | ||||
| 2026-05-11 | 2026-05-07 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 2,8800 | 8.680 | 25 | 20.318 | ||||
| 2025-12-16 | 2025-12-12 | 4 | NEIS JOHN | CLRB | Common Stock | I | 3,6969 | -198 | -1 | 10 | ||||
| 2025-07-03 | 2025-07-02 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 4,9900 | 10.000 | 50 | 11.638 | ||||
| 2025-07-03 | 2025-07-02 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 4,9900 | 10.000 | 50 | 12.768 | ||||
| 2025-07-03 | 2025-07-02 | 4 | Kolean Chad J | CLRB | Common Stock | D | 4,9900 | 5.000 | 25 | 6.418 | ||||
| 2025-03-12 | 2025-01-10 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 0,2800 | 30.000 | 8 | 83.141 | ||||
| 2023-12-12 | 2023-12-08 | 4 | Lea Darrell Shane | CLRB | Common Stock | D | 39.599 | 39.599 | ||||||
| 2023-12-12 | 2023-12-08 | 4 | Kolean Chad J | CLRB | Common Stock | D | 42.554 | 42.578 | ||||||
| 2023-12-12 | 2023-12-08 | 4 | Shustov Andrei | CLRB | Common Stock | D | 47.856 | 55.038 | ||||||
| 2023-12-12 | 2023-12-08 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 40.596 | 49.236 | ||||||
| 2023-12-12 | 2023-12-08 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 42.927 | 53.141 | ||||||
| 2023-03-16 | 3 | Shustov Andrei | CLRB | Common Stock | D | 7.182 | ||||||||
| 2022-04-15 | 3/A | Kolean Chad J | CLRB | Common Stock | D | 240 | ||||||||
| 2022-02-24 | 2022-02-22 | 4 | Kolean Chad J | CLRB | Stock option (right to buy) | D | 0,49 | 150.000 | 150.000 | |||||
| 2022-01-27 | 2022-01-25 | 4 | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 0,55 | 1.419.000 | 1.419.000 | |||||
| 2022-01-27 | 2022-01-25 | 4 | Elefant Dov | CLRB | Stock option (right to buy) | D | 0,55 | 422.000 | 422.000 | |||||
| 2022-01-27 | 2022-01-25 | 4 | Longcor Jarrod | CLRB | Stock option (right to buy) | D | 0,55 | 475.000 | 475.000 | |||||
| 2021-09-14 | 2021-09-14 | 4 | Swirsky Douglas J | CLRB | Common Stock | D | 1,0400 | 25.000 | 26 | 25.000 | ||||
| 2021-09-07 | 2021-09-03 | 4 | DRISCOLL FREDERICK W | CLRB | Common Stock | D | 1,0426 | 19.417 | 20 | 19.417 | ||||
| 2021-07-02 | 2021-06-30 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 1,19 | 78.000 | 78.000 | |||||
| 2021-07-02 | 2021-06-30 | 4 | DRISCOLL FREDERICK W | CLRB | Stock option (right to buy) | D | 1,19 | 78.000 | 78.000 | |||||
| 2021-07-02 | 2021-06-30 | 4 | Swirsky Douglas J | CLRB | Stock option (right to buy) | D | 1,19 | 117.000 | 117.000 | |||||
| 2021-07-02 | 2021-06-30 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 1,19 | 78.000 | 78.000 | |||||
| 2021-07-02 | 2021-06-30 | 4 | Chanan-Khan Asher | CLRB | Stock option (right to buy) | D | 1,19 | 78.000 | 78.000 | |||||
| 2021-03-19 | 2021-03-18 | 4 | NEIS JOHN | CLRB | Series A Warrants | D | 30,40 | 0,2522 | -23.232 | -6 | 0 | |||
| 2021-03-19 | 2021-03-17 | 4 | NEIS JOHN | CLRB | Series A Warrants | D | 30,40 | 0,2775 | -58.640 | -16 | 23.232 | |||
| 2021-03-16 | 2021-03-16 | 4 | NEIS JOHN | CLRB | Series A Warrants | D | 30,40 | 0,3091 | -100.515 | -31 | 81.872 | |||
| 2021-03-16 | 2021-03-15 | 4 | NEIS JOHN | CLRB | Series A Warrants | D | 30,40 | 0,2652 | -11.200 | -3 | 182.387 | |||
| 2021-03-16 | 2021-03-12 | 4 | NEIS JOHN | CLRB | Series A Warrants | D | 30,40 | 0,2668 | -41.155 | -11 | 193.587 | |||
| 2021-03-05 | 2021-03-04 | 4 | Elefant Dov | CLRB | Stock option (right to buy) | D | 1,74 | 430.000 | 430.000 | |||||
| 2021-03-05 | 2021-03-04 | 4 | CARUSO JAMES V | CLRB | Series A Warrants | D | 30,40 | 0,1857 | 46.948 | 9 | 0 | |||
| 2021-03-05 | 2021-03-04 | 4 | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 1,74 | 1.600.000 | 1.600.000 | |||||
| 2021-03-05 | 2021-03-04 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 1,6978 | 5.100 | 9 | 86.401 | ||||
| 2021-03-05 | 2021-03-04 | 4 | Friend John E. II | CLRB | Stock option (right to buy) | D | 1,74 | 330.000 | 330.000 | |||||
| 2021-03-05 | 2021-03-04 | 4 | Longcor Jarrod | CLRB | Stock option (right to buy) | D | 1,74 | 450.000 | 450.000 | |||||
| 2020-12-28 | 2020-12-28 | 4 | Elefant Dov | CLRB | Common Stock | D | 1,3500 | 7.407 | 10 | 11.755 | ||||
| 2020-12-28 | 2020-12-28 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 1,3500 | 29.630 | 40 | 102.148 | ||||
| 2020-12-28 | 2020-12-28 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 1,3500 | 37.037 | 50 | 81.301 | ||||
| 2020-07-06 | 3 | Friend John E. II | CLRB | Common Stock | D | 6.666 | ||||||||
| 2020-07-06 | 3 | Friend John E. II | CLRB | Common Stock | D | 6.666 | ||||||||
| 2020-07-06 | 3 | Friend John E. II | CLRB | Common Stock | D | 6.666 | ||||||||
| 2020-07-06 | 2020-07-01 | 4 | Friend John E. II | CLRB | Stock option (right to buy) | D | 1,34 | 100.000 | 100.000 | |||||
| 2020-06-25 | 2020-06-24 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 1,28 | 50.000 | 50.000 | |||||
| 2020-06-25 | 2020-06-24 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 1,28 | 50.000 | 50.000 | |||||
| 2020-06-25 | 2020-06-24 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 1,28 | 50.000 | 50.000 | |||||
| 2020-06-25 | 2020-06-24 | 4 | DRISCOLL FREDERICK W | CLRB | Stock option (right to buy) | D | 1,28 | 50.000 | 50.000 | |||||
| 2020-06-25 | 2020-06-24 | 4 | Swirsky Douglas J | CLRB | Stock option (right to buy) | D | 1,28 | 80.000 | 80.000 | |||||
| 2020-06-08 | 2020-06-04 | 4 | HILL STEPHEN A | CLRB | Common Stock | D | 1,0799 | 18.000 | 19 | 18.000 | ||||
| 2020-06-08 | 2020-06-05 | 4 | CARUSO JAMES V | CLRB | Series H Warrants | D | 1,21 | 0,0100 | 10.870 | 0 | 10.870 | |||
| 2020-06-08 | 2020-06-05 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 1,1450 | 21.740 | 25 | 44.264 | ||||
| 2020-06-08 | 2020-06-05 | 4 | Longcor Jarrod | CLRB | Series H Warrants | D | 1,21 | 0,0100 | 32.609 | 0 | 32.609 | |||
| 2020-06-08 | 2020-06-05 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 1,1450 | 65.218 | 75 | 72.518 | ||||
| 2020-06-08 | 2020-06-05 | 4 | Elefant Dov | CLRB | Series H Warrants | D | 1,21 | 0,0100 | 2.174 | 0 | 2.174 | |||
| 2020-06-08 | 2020-06-05 | 4 | Elefant Dov | CLRB | Common Stock | D | 1,1450 | 4.348 | 5 | 4.348 | ||||
| 2020-03-05 | 2020-02-03 | 4/A | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 2,71 | 100.000 | 100.000 | |||||
| 2020-03-05 | 2020-02-03 | 4/A | Longcor Jarrod | CLRB | Stock option (right to buy) | D | 2,71 | 40.000 | 40.000 | |||||
| 2020-03-05 | 2020-02-03 | 4/A | Elefant Dov | CLRB | Stock Option (right to buy) | D | 2,71 | 10.000 | 10.000 | |||||
| 2020-02-04 | 2020-02-03 | 4 | CARUSO JAMES V | CLRB | Common stock | D | 2,7100 | 100.000 | 271 | 100.000 | ||||
| 2020-02-04 | 2020-02-03 | 4 | Longcor Jarrod | CLRB | Common stock | D | 2,7100 | 40.000 | 108 | 40.000 | ||||
| 2020-02-04 | 2020-02-03 | 4 | Elefant Dov | CLRB | Common stock | D | 2,7100 | 10.000 | 27 | 10.000 | ||||
| 2020-01-08 | 2020-01-06 | 4 | Grachev Igor D | CLRB | Stock Option (right to buy) | D | 2,46 | 80.000 | 80.000 | |||||
| 2019-09-11 | 2019-09-10 | 4 | Elefant Dov | CLRB | Stock Option (right to buy) | D | 2,32 | 90.000 | 90.000 | |||||
| 2019-06-14 | 2019-06-13 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 2,15 | 6.500 | 6.500 | |||||
| 2019-06-14 | 2019-06-13 | 4 | Swirsky Douglas J | CLRB | Stock option (right to buy) | D | 2,15 | 9.750 | 9.750 | |||||
| 2019-06-14 | 2019-06-13 | 4 | DRISCOLL FREDERICK W | CLRB | Stock option (right to buy) | D | 2,15 | 6.500 | 6.500 | |||||
| 2019-06-14 | 2019-06-13 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 2,15 | 6.500 | 6.500 | |||||
| 2019-06-14 | 2019-06-13 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 2,15 | 6.500 | 6.500 | |||||
| 2019-03-01 | 2019-02-28 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 2,0025 | 100 | 0 | 7.300 | ||||
| 2019-01-18 | 2019-01-17 | 4 | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 1,99 | 75.000 | 75.000 | |||||
| 2019-01-18 | 2019-01-17 | 4 | POSNER BRIAN M | CLRB | Stock option (right to buy) | D | 1,99 | 30.000 | 30.000 | |||||
| 2019-01-18 | 2019-01-17 | 4 | Longcor Jarrod | CLRB | Stock option (right to buy) | D | 1,99 | 30.000 | 30.000 | |||||
| 2018-11-30 | 2018-11-30 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 2,2820 | 1.000 | 2 | 22.354 | ||||
| 2018-11-30 | 2018-11-29 | 4 | HILL STEPHEN A | CLRB | Warrants | D | 468,00 | 0,0510 | 530 | 0 | 0 | |||
| 2018-11-30 | 2018-11-29 | 4 | HILL STEPHEN A | CLRB | Series A Warrants | D | 30,40 | 0,0977 | 9.390 | 1 | 0 | |||
| 2018-11-30 | 2018-11-29 | 4 | HILL STEPHEN A | CLRB | Common Stock | D | 2,2100 | -53 | -0 | 0 | ||||
| 2018-11-30 | 2018-11-29 | 4 | HILL STEPHEN A | CLRB | Common Stock | D | 2,2101 | -939 | -2 | 53 | ||||
| 2018-10-15 | 2018-10-12 | 4 | DRISCOLL FREDERICK W | CLRB | Stock option (right to buy) | D | 2,61 | 13.000 | 13.000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 2,61 | 13.000 | 13.000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 2,61 | 13.000 | 13.000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 2,61 | 13.000 | 13.000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 2,61 | 150.000 | 150.000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | Longcor Jarrod | CLRB | Stock option (right to buy) | D | 2,61 | 63.000 | 63.000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | Friend John E. II | CLRB | Stock option (right to buy) | D | 2,61 | 63.000 | 63.000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | POSNER BRIAN M | CLRB | Stock option (right to buy) | D | 2,61 | 54.000 | 54.000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | Swirsky Douglas J | CLRB | Stock option (right to buy) | D | 2,61 | 19.500 | 19.500 | |||||
| 2018-08-17 | 2018-08-16 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 2,7100 | 500 | 1 | 7.200 | ||||
| 2018-04-06 | 2018-04-06 | 4 | POSNER BRIAN M | CLRB | Stock option (right to buy) | D | 1,17 | 80.000 | 80.000 | |||||
| 2018-03-14 | 2018-03-12 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 1,1972 | -34.000 | -41 | 213.548 | ||||
| 2018-03-14 | 2018-03-13 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 1,1844 | -13.000 | -15 | 67.000 | ||||
| 2017-11-16 | 2017-11-14 | 4 | NEIS JOHN | CLRB | Common Stock, par value $0.00001 per share | I | 1,4942 | -5.214 | -8 | 626.103 | ||||
| 2017-09-25 | 2017-09-18 | 4 | Longcor Jarrod | CLRB | Employee Stock Option (right to buy) | D | 1,83 | 25.000 | 25.000 | |||||
| 2017-06-01 | 2017-05-31 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 1,74 | 10.000 | 10.000 | |||||
| 2017-06-01 | 2017-05-31 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 1,74 | 10.000 | 10.000 | |||||
| 2017-06-01 | 2017-05-31 | 4 | DRISCOLL FREDERICK W | CLRB | Stock option (right to buy) | D | 1,74 | 10.000 | 10.000 | |||||
| 2017-06-01 | 2017-05-31 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 1,74 | 10.000 | 10.000 | |||||
| 2017-06-01 | 2017-05-31 | 4 | Swirsky Douglas J | CLRB | Stock option (right to buy) | D | 1,74 | 10.000 | 10.000 | |||||
| 2017-04-20 | 2017-04-18 | 4 | CARUSO JAMES V | CLRB | Common stock | D | 200.000 | 247.548 | ||||||
| 2017-04-20 | 2017-04-18 | 4 | Longcor Jarrod | CLRB | Common stock | D | 80.000 | 80.000 | ||||||
| 2017-04-20 | 2017-04-18 | 4 | Kolean Chad J | CLRB | Common stock | D | 80.000 | 80.000 | ||||||
| 2017-04-18 | 2017-04-17 | 4 | Friend John E. II | CLRB | Common stock | D | 100.000 | 100.000 | ||||||
| 2016-11-30 | 2016-11-29 | 4 | NEIS JOHN | CLRB | Series C Warrants (right to buy) | I | 1,50 | 0,0100 | 333.333 | 3 | 607.946 | |||
| 2016-11-30 | 2016-11-29 | 4 | NEIS JOHN | CLRB | Common Stock, par value $0.00001 per share | I | 1,4900 | 333.333 | 497 | 631.317 | ||||
| 2016-11-01 | 2016-10-31 | 4 | Hertzberg Richard | clrB | Cellectar Biosciences, Inc. common stock (CLRB) | D | 2,0290 | -21.000 | -43 | 280.000 | ||||
| 2016-11-01 | 2016-08-09 | 4 | Hertzberg Richard | clrB | Cellectar Biosciences Inc. Warrant (CLRBW) | D | 46,80 | 1,7500 | -40.916 | -72 | 0 | |||
| 2016-08-12 | 2016-07-15 | 4 | Longcor Jarrod | CLRB | Employee Stock Option (right to buy) | D | 2,93 | 75.000 | 75.000 | |||||
| 2016-07-07 | 2016-07-05 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 3,34 | 0,0100 | 22.500 | 0 | 23.500 | |||
| 2016-07-06 | 2016-07-05 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 3,34 | 0,0100 | 22.500 | 0 | 24.750 | |||
| 2016-07-06 | 2016-07-05 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 3,34 | 0,0100 | 22.500 | 0 | 25.434 | |||
| 2016-06-14 | 2015-12-28 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0,7200 | 75.000 | 54 | 75.000 | ||||
| 2016-06-14 | 2015-12-24 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0,7900 | 50.000 | 40 | 50.000 | ||||
| 2016-06-14 | 2015-12-22 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0,9100 | 5.000 | 5 | 5.000 | ||||
| 2016-06-14 | 2015-12-16 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0,9100 | 19.592 | 18 | 19.592 | ||||
| 2016-06-14 | 2015-12-11 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0,9240 | 16.250 | 15 | 16.250 | ||||
| 2016-06-14 | 2015-12-08 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0,9225 | 10.000 | 9 | 10.000 | ||||
| 2016-06-14 | 2014-10-03 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 2,2500 | 10.000 | 22 | 10.000 | ||||
| 2016-06-14 | 2014-09-19 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 2,6700 | 20.000 | 53 | 20.000 | ||||
| 2016-06-14 | 2014-08-20 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences Inc. Warrant (CLRBW) | D | 4,68 | 0,0100 | 409.158 | 4 | 409.158 | |||
| 2016-06-14 | 2014-08-20 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 3,7500 | 409.158 | 1.534 | 409.158 | ||||
| 2016-06-14 | 2011-12-11 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. Warrant 12/5/2011 | D | 12,00 | 0,0002 | 10.000 | 0 | 10.000 | |||
| 2016-06-14 | 2011-12-05 | 5 | Hertzberg Richard | CLRB | Novelos Therapeutics, Inc. New (NVLT) | D | 12,0000 | 10.000 | 120 | 10.000 | ||||
| 2016-06-14 | 2016-04-21 | 4 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. | D | 1,9000 | 3.758 | 7 | 301.000 | ||||
| 2016-06-14 | 2016-04-15 | 4 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. Series A Warrant (CLRBZ) | D | 3,04 | 0,0100 | 234.742 | 2 | 41.915 | |||
| 2016-06-14 | 2016-04-15 | 4 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 2,1200 | 234.742 | 498 | 297.242 | ||||
| 2016-05-23 | 2016-05-12 | 4 | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 1,48 | 0,0100 | 200.000 | 2 | 237.500 | |||
| 2016-05-23 | 2016-05-12 | 4 | Kolean Chad J | CLRB | Stock option (right to buy) | D | 1,48 | 0,0100 | 50.000 | 0 | 52.000 | |||
| 2016-05-23 | 2016-05-12 | 4 | Weichert Jamey P | CLRB | Stock option (right to buy) | D | 1,48 | 0,0100 | 40.000 | 0 | 42.895 | |||
| 2016-04-25 | 3 | WISCONSIN ALUMNI RESEARCH FOUNDATION | CLRB | Common Stock | D | 938.968 | ||||||||
| 2016-04-25 | 3 | WISCONSIN ALUMNI RESEARCH FOUNDATION | CLRB | Common Stock | D | 938.968 | ||||||||
| 2016-04-21 | 2016-04-20 | 4 | CARUSO JAMES V | CLRB | Series A Warrants | D | 3,04 | 0,0100 | 46.948 | 0 | 46.948 | |||
| 2016-04-21 | 2016-04-20 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 2,1200 | 46.948 | 100 | 47.548 | ||||
| 2016-04-21 | 2016-04-20 | 4 | BERNS PAUL L | CLRB | Series A Warrants | D | 3,04 | 0,0100 | 117.371 | 1 | 117.371 | |||
| 2016-04-21 | 2016-04-20 | 4 | BERNS PAUL L | CLRB | Common Stock, par value $0.00001 per share | D | 2,1200 | 117.371 | 249 | 117.371 | ||||
| 2016-04-21 | 2016-04-20 | 4 | NEIS JOHN | CLRB | Series A Warrants | I | 3,04 | 0,0100 | 234.742 | 2 | 274.613 | |||
| 2016-04-21 | 2016-04-20 | 4 | NEIS JOHN | CLRB | Common Stock, par value $0.00001 per share | I | 2,1200 | 234.742 | 498 | 297.984 | ||||
| 2016-04-21 | 2016-04-20 | 4 | HILL STEPHEN A | CLRB | Series A Warrants | D | 3,04 | 0,0100 | 9.390 | 0 | 9.920 | |||
| 2016-04-21 | 2016-04-20 | 4 | HILL STEPHEN A | CLRB | Common Stock, par value $0.00001 per share | D | 2,1200 | 9.390 | 20 | 9.920 | ||||
| 2016-01-04 | 2015-12-31 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,6955 | -35.253 | -25 | 0 | ||||
| 2016-01-04 | 2015-12-30 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,6873 | -64.747 | -45 | 35.253 | ||||
| 2015-12-30 | 2015-12-29 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,6929 | -82.847 | -57 | 100.000 | ||||
| 2015-12-29 | 2015-12-28 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,6903 | -150.975 | -104 | 182.847 | ||||
| 2015-12-29 | 2015-12-24 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,7596 | -216.991 | -165 | 333.822 | ||||
| 2015-12-23 | 2015-12-22 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,9046 | -7.938 | -7 | 550.813 | ||||
| 2015-12-22 | 2015-12-21 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,9223 | -20.621 | -19 | 558.751 | ||||
| 2015-12-22 | 2015-12-18 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,8988 | -7.000 | -6 | 579.372 | ||||
| 2015-12-18 | 2015-12-17 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,8816 | -18.240 | -16 | 586.372 | ||||
| 2015-12-18 | 2015-12-16 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,8644 | -52.985 | -46 | 604.612 | ||||
| 2015-12-16 | 2015-12-15 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0,8243 | -44.965 | -37 | 657.597 | ||||
| 2015-12-08 | 2015-12-04 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1,0619 | -49.950 | -53 | 702.562 | ||||
| 2015-12-08 | 2015-12-04 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1,1400 | -1.000 | -1 | 752.512 | ||||
| 2015-12-03 | 2015-12-01 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1,0405 | -42.110 | -44 | 753.512 | ||||
| 2015-12-01 | 2015-11-25 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1,2026 | -4.378 | -5 | 795.622 | ||||
| 2015-11-25 | 2015-11-24 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1,2747 | -67.102 | -86 | 800.000 | ||||
| 2015-11-25 | 2015-11-23 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1,2110 | -106.700 | -129 | 867.102 | ||||
| 2015-11-25 | 2015-11-24 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 1,3020 | 1.000 | 1 | 6.000 | ||||
| 2015-11-24 | 2015-11-20 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 1,1593 | 1.000 | 1 | 5.000 | ||||
| 2015-11-23 | 2015-11-20 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1,1518 | -88.745 | -102 | 973.802 | ||||
| 2015-11-23 | 2015-11-19 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1,3794 | -8.061 | -11 | 10.625.547 | ||||
| 2015-11-19 | 2015-11-19 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 1,5000 | 2.000 | 3 | 4.000 | ||||
| 2015-11-19 | 2015-11-18 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 1,3949 | 2.000 | 3 | 2.000 | ||||
| 2015-10-29 | 2015-10-28 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,0000 | -99 | -0 | 1.070.608 | ||||
| 2015-10-26 | 2015-10-23 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,0000 | -2.000 | -4 | 1.070.707 | ||||
| 2015-10-26 | 2015-10-22 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,0000 | -6.866 | -14 | 1.072.707 | ||||
| 2015-10-08 | 2015-10-06 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,0000 | -2.554 | -5 | 1.079.573 | ||||
| 2015-10-06 | 2015-10-05 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,1082 | -2.800 | -6 | 1.082.127 | ||||
| 2015-10-06 | 2015-10-02 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,0000 | -4.700 | -9 | 1.084.927 | ||||
| 2015-10-02 | 2015-10-01 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,0599 | -21.600 | -44 | 1.089.627 | ||||
| 2015-10-02 | 2015-09-30 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,0000 | -6.340 | -13 | 1.111.227 | ||||
| 2015-09-30 | 2015-09-29 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,1500 | -1.701 | -4 | 1.117.567 | ||||
| 2015-09-30 | 2015-09-28 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,6500 | -10.000 | -26 | 1.119.268 | ||||
| 2015-09-30 | 2015-09-28 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2,1699 | -13.100 | -28 | 1.129.268 | ||||
| 2015-06-10 | 2015-06-09 | 4 | BERNS PAUL L | CLRB | Stock Option (right to buy) | D | 2,64 | 5.000 | 5.000 | |||||
| 2015-06-10 | 2015-06-09 | 4 | NEIS JOHN | CLRB | Stock Option (right to buy) | D | 2,64 | 5.000 | 5.000 | |||||
| 2015-06-10 | 2015-06-09 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 2,64 | 5.000 | 5.000 | |||||
| 2015-03-04 | 2015-02-26 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 2,69 | 5.500 | 5.500 | |||||
| 2015-03-04 | 2015-02-26 | 4 | BERNS PAUL L | CLRB | Stock Option (right to buy) | D | 2,69 | 5.000 | 5.000 | |||||
| 2015-03-04 | 2015-02-26 | 4 | NEIS JOHN | CLRB | Stock Option (right to buy) | D | 2,69 | 5.000 | 5.000 | |||||
| 2015-03-04 | 2015-02-26 | 4 | Genn John Patrick | CLRB | Stock option (right to buy) | D | 2,69 | 10.000 | 10.000 | |||||
| 2014-12-18 | 2014-11-24 | 4 | Szakacs Cameron | CLRB | Employee Stock Option (right to buy) | D | 2,74 | 50.000 | 50.000 | |||||
| 2014-09-10 | 2014-09-08 | 4 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 3,0000 | 182 | 1 | 1.142.368 | ||||
| 2014-09-09 | 2014-09-08 | 4 | Genn John Patrick | CLRB | Stock purchase warrant (right to buy) | D | 4,68 | 0,0100 | 10.000 | 0 | 77.083 | |||
| 2014-09-09 | 2014-08-29 | 4 | Genn John Patrick | CLRB | Stock purchase warrant (right to buy) | D | 4,68 | 0,0100 | 15.000 | 0 | 67.083 | |||
| 2014-09-09 | 2014-08-28 | 4 | Genn John Patrick | CLRB | Stock purchase warrant (right to buy) | D | 4,68 | 0,0100 | 22.000 | 0 | 52.083 | |||
| 2014-09-09 | 2014-08-27 | 4 | Genn John Patrick | CLRB | Stock purchase warrant (right to buy) | D | 4,68 | 0,0100 | 3.000 | 0 | 30.083 | |||
| 2014-09-08 | 3 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 2.132.000 | ||||||||
| 2014-09-08 | 3 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 2.132.000 | ||||||||
| 2014-09-08 | 2014-08-22 | 4 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 3,0000 | 5.699 | 17 | 1.142.186 | ||||
| 2014-09-08 | 2014-08-19 | 4 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 3,0500 | 65.687 | 200 | 1.136.487 | ||||
| 2014-09-08 | 2014-08-18 | 4 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 3,0500 | 4.800 | 15 | 1.070.800 | ||||
| 2014-09-05 | 3 | Cormorant Global Healthcare Master Fund, LP | CLRB | Common Stock | I | 1.060.000 | ||||||||
| 2014-09-05 | 3 | Cormorant Global Healthcare Master Fund, LP | CLRB | Common Stock | I | 1.060.000 | ||||||||
| 2014-09-05 | 3 | Cormorant Global Healthcare Master Fund, LP | CLRB | Common Stock | I | 1.060.000 | ||||||||
| 2014-09-05 | 3 | Cormorant Global Healthcare Master Fund, LP | CLRB | Common Stock | I | 1.060.000 | ||||||||
| 2014-09-05 | 3 | Cormorant Global Healthcare Master Fund, LP | CLRB | Common Stock | I | 1.060.000 | ||||||||
| 2014-08-22 | 3/A | NEIS JOHN See Foonote | CLRB | Common Stock, par value $0.00001 per share | I | 363.715 | ||||||||
| 2014-08-22 | 2014-08-20 | 4 | HILL STEPHEN A | CLRB | Stock purchase warrant (right to buy) | D | 4,68 | 0,0100 | 5.300 | 0 | 21.351 | |||
| 2014-08-22 | 2014-08-20 | 4 | HILL STEPHEN A | CLRB | Common Stock, par value $0.00001 per share | D | 3,7500 | 5.300 | 20 | 5.300 | ||||
| 2014-08-22 | 2014-08-20 | 4 | NEIS JOHN See Foonote | CLRB | Stock Purchase Warrant (right to buy) | I | 4,68 | 0,0100 | 138.711 | 1 | 268.711 | |||
| 2014-08-22 | 2014-08-20 | 4 | NEIS JOHN See Foonote | CLRB | Convertible Debenture (right to buy) | I | 10,00 | 3,7500 | -50.000 | -188 | 0 | |||
| 2014-08-22 | 2014-08-20 | 4 | NEIS JOHN See Foonote | CLRB | Stock Purchase Warrant (right to buy) | I | 4,68 | 0,0100 | 130.000 | 1 | 130.000 | |||
| 2014-08-22 | 2014-08-20 | 4 | NEIS JOHN See Foonote | CLRB | Common Stock, par value $0.00001 per share | I | 3,7500 | 138.711 | 520 | 632.426 | ||||
| 2014-08-22 | 2014-08-20 | 4 | NEIS JOHN See Foonote | CLRB | Common Stock, par value $0.00001 per share | I | 3,7500 | 130.000 | 488 | 493.715 | ||||
| 2014-08-22 | 2014-08-20 | 4 | Pedder Simon | CLRB | Stock purchase warrant (right to buy) | D | 4,68 | 0,0100 | 13.300 | 0 | 277.578 | |||
| 2014-08-22 | 2014-08-20 | 4 | Pedder Simon | CLRB | Common Stock, par value $0.00001 per share | D | 3,7500 | 13.300 | 50 | 13.300 | ||||
| 2014-08-18 | 3 | Genn John Patrick | CLRB | Common Stock, par value $0.00001 per share | D | 7.064 | ||||||||
| 2014-08-18 | 3 | Genn John Patrick | CLRB | Common Stock, par value $0.00001 per share | D | 7.064 | ||||||||
| 2014-08-18 | 3 | Weichert Jamey P | CLRB | Common Stock, par value $0.00001 per share | D | 470.672 | ||||||||
| 2014-08-18 | 3 | Weichert Jamey P | CLRB | Common Stock, par value $0.00001 per share | D | 470.672 |
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)
